Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY : Advanced Search
EVENT DATES
Mar 2018
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728293031 
EXHIBITION HALL DATES
Mar 2018
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728293031 

Venue

Rosen Shingle Creek 9939 Universal Blvd., Orlando , Florida 32819
Tel: (866) 996-9939
Website
Google Map

NCCN 23rd Annual Conference: Advancing the Standard of Cancer Care - National Comprehensive Cancer Network

75 $ $210 - $1,645

Overview

Event Overview:

In 2018 educational sessions feature the latest advances in oncology care, plus interactive Patient Case Studies & Panel Discussions. NCCN will also offer concurrent sessions so that attendees can customize their learning experience.

This conference is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

This conference is approved for AMA PRA Category 1 Credits™ for physicians and is also certified for nurses, pharmacists, and other oncology professionals. NCCN will also seek approval for case manager and tumor registrar clock hours.

About NCCN:

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

Agenda

Mar 22   

7:00 – 8:00 AM


 

Breakfast, Exhibits, and General Poster Session (Exhibition Hall)


 

8:15 – 8:25 AM

Welcome and Opening Remarks

Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

 

8:30 – 9:15 AM


 

New NCCN Guidelines®: Cancer in People Living with HIV

Gita Suneja, MD
Duke Cancer Institute


 

9:20 – 10:05 AM


 

New Therapies for Ovarian Cancer

Deborah K. Armstrong, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


 

10:05 – 10:35 AM


 

Break, Exhibits, and General Poster Session (Exhibition Hall)


 

10:35 – 11:10 AM


 

Management of Chronic Myeloid Leukemia During Pregnancy

Ellin Berman, MD
Memorial Sloan Kettering Cancer Center


 

11:15 AM – 12:15 PM


 

NCCN Guidelines® Updates: Prostate Cancer and Prostate Cancer Early Detection
 

Reducing Harms and Increasing Benefits of Prostate Cancer Early Detection

Peter R. Carroll, MD, MPH
UCSF Helen Diller Family Comprehensive Cancer Center

 

New Approaches to the Management of Prostate Cancer


James L. Mohler, MD
Roswell Park Cancer Institute


 

12:15 – 1:30 PM

Lunch, Exhibits, and General Poster Session (Exhibition Hall)

Lunch Symposium§ 12:25 – 1:25 PM

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy 

Jointly provided by NCCN and Clinical Care Options, LLC


 

1:30 – 2:45 PM


 

NCCN Guidelines® Updates: Colon and Rectal Cancers

Management of Locoregional Rectal Cancer

Christopher G. Willett, MD
Duke Cancer Institute

Optimizing Adjuvant Therapy for Localized Colon Cancer

Axel Grothey, MD
Mayo Clinic Cancer Center

Treatment Selection in Advanced Colorectal Cancer

Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center

2:45 – 3:10 PM

Break, Exhibits, and General Poster Session (Exhibition Hall)

3:10 – 3:55 PM


 

Updates to the Management of Kidney Cancer 

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center

4:00 – 4:45 PM


 

NCCN Guidelines® Updates: Management of Multiple Myeloma

Shaji K. Kumar, MD
Mayo Clinic Cancer Center

4:45 – 5:30 PM

Free Time

5:30 – 7:30 PM

Welcome Reception (Exhibition Hall)

 
Kids' Fun Night! (Gatlin A1)

Mar 23   

7:00 – 8:00 AM

Breakfast, Exhibits, and General Poster Session (Exhibition Hall)

8:00 – 9:00 AM

NCCN Keynote Session: Transforming Cancer Care in America

This keynote session will provide updates and perspectives on the continuously evolving and ongoing transformation of cancer care in America and will include the following presentations:

The CMS Oncology Care Model: Where We’ve Been, and Where We’re Going
 

Ron Kline, MD, FAAP
Medical Officer, Patient Care Models Group
Center for Medicare & Medicaid Innovation, CMS

A Managed Care Perspective: Where We Are, and Where We Could Go

Lee N. Newcomer, MD, MHA
 

 

9:00 – 10:10 AM

 

 NCCN Roundtable Discussion:
Emerging Issues in Oncology – A Multidisciplinary Discussion on Delivering and Receiving Cancer Care in Value-Based Healthcare Models

 Moderator: Clifford Goodman, PhD, Senior Vice President, The Lewin Group

This non-accredited roundtable will provide an opportunity for a varied group of stakeholders including 
providers, payers, patient advocates, industry, and government to discuss delivering and receiving cancer care 
within value-based healthcare models.

Panelists for this non-accredited roundtable discussion will be posted once confirmed. 
This session is supported separately from the general session.

 

10:10 – 10:35 AM


 

Break, Exhibits, and General Poster Session (Exhibition Hall)


 

10:35 – 11:10 AM


 

Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients with Cancer

Gerald Soff, MD
Memorial Sloan Kettering Cancer Center

11:15 AM – 12:15 PM


 

NCCN Guidelines®: Melanoma

New NCCN Guidelines®: Uveal Melanoma

Christopher A. Barker, MD

Memorial Sloan Kettering Cancer Center

Treatment of Recurrent or Progressive Distant Metastatic Melanoma
 

April K. Salama, MD
Duke Cancer Institute


 

12:15 – 1:30 PM

 

Lunch, Exhibits, and General Poster Session (Exhibition Hall)

1:30 – 2:45 PM

 NCCN Guidelines® Updates: Breast Cancer

Updates on HER2-Positive Breast Cancer Treatment

Sharon H. Giordano, MD, MPH
The University of Texas MD Anderson Cancer Center

New Developments in the Management of Triple Negative Breast Cancer

Anthony D. Elias, MD
University of Colorado Cancer Center

Treatment of Hormone-Sensitive Advanced Breast Cancer

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


 

2:45 – 3:10 PM

Break, Exhibits, and General Poster Session (Exhibition Hall)

3:10 – 4:10 PM

NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™):
Adult Cancer Pain and Palliative Care

Maria Dans, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Robert A. Swarm, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

 

4:15 – 5:00 PM

The Role of Molecular Pathology in Glioma Staging and Treatment of Anaplastic Gliomas

Matthias Holdhoff, MD, PhD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Mar 24   

7:00 – 8:00 AM

Breakfast (Gatlin Ballroom Foyer)

8:00 – 8:45 AM

NCCN Guidelines® Updates: Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer

Karen Reckamp, MD, MS
City of Hope Comprehensive Cancer Center


 

8:50 – 9:35 AM

New NCCN Guidelines®: Recognition and Management of Immunotherapy-Related Toxicity 

John A. Thompson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

9:40 – 10:25 AM

Head and Neck Cancers: The Advantages of Advanced Radiation Therapy and the Importance of Supportive Care

Sharon Spencer, MD
University of Alabama at Birmingham Comprehensive Cancer Center

10:25 – 10:40 AM

Break (Gatlin Ballroom Foyer)

10:40 – 11:25 AM

Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of 
Acute Myeloid Leukemia

Martin S. Tallman, MD
Memorial Sloan Kettering Cancer Center

11:30 AM – 12:15 PM
 

Updates on Screening and Diagnosis of Hepatocellular Carcinoma 

Anne M. Covey, MD
Memorial Sloan Kettering Cancer Center

12:15 – 1:00 PM

Lunch (Gatlin Ballroom Foyer)

1:00 – 1:45 PM


 

Emerging Treatment Options for Ph-positive and Ph-negative Acute Lymphoblastic Leukemia 

Patrick A. Brown, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

1:50 – 2:35 PM

CAR T Cells and Impact on Cancer Treatment: Lessons from Acute Lymphoblastic Leukemia

Bijal Shah, MD
Moffitt Cancer Center

2:40 – 3:25 PM

The Changing Treatment Landscape for Metastatic Urothelial Carcinoma

Thomas W. Flaig, MD
University of Colorado Cancer Center

3:25 – 3:30 PM

Closing Remarks

Gary J. Weyhmuller, MBA, SPHR
Executive Vice President/Chief Operating Officer
National Comprehensive Cancer Network

Keynote Speakers

Ron Kline, MD, FAAP

Medical Officer, Patient Care Models Group Center for Medicare & Medicaid Innovation, CMS

Ron Kline, MD, FAAP, is a medical officer at the Centers for Medicare and Medicaid Services supporting the Oncology Care Model. He is also a volunteer pediatric hematology/oncology faculty member at John Hopkins Hospital in Baltimore, MD.

SERVICE PROVIDERS

HOTELS NEARBY

RELATED EVENTS +

MORE events +